Nanjing Vazyme Biotech Co., Ltd. (SHSE:688105) announces a share repurchase program. Under the program, the company will repurchase CNY 160 million worth of its shares. The shares will be purchased at a price not exceeding CNY 30 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months.

On May 6, 2024, the company announced that the repurchased shares will be used for cancellation and corresponding reduction of registered capital. The repurchased shares will no longer be used for the implementation of ESOP or equity incentive plan.